Enanta Pharmaceuticals (ENTA) Selling, General & Administrative (2012 - 2026)
Enanta Pharmaceuticals (ENTA) Selling, General & Administrative (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -355.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 101.25 Mn |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - | 9.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.57 Mn |
| Dec 31, 2025 | 9.01 Mn |
| Sep 30, 2025 | 9.70 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 11.39 Mn |
| Dec 31, 2024 | 12.85 Mn |
| Sep 30, 2024 | 13.68 Mn |
| Jun 30, 2024 | 13.41 Mn |
| Mar 31, 2024 | 14.24 Mn |
| Dec 31, 2023 | 16.52 Mn |
| Sep 30, 2023 | 13.80 Mn |
| Jun 30, 2023 | 12.62 Mn |
| Mar 31, 2023 | 13.78 Mn |
| Dec 31, 2022 | 12.70 Mn |
| Sep 30, 2022 | 12.57 Mn |
| Jun 30, 2022 | 12.93 Mn |
| Mar 31, 2022 | 10.48 Mn |
| Dec 31, 2021 | 9.51 Mn |
| Sep 30, 2021 | 8.36 Mn |
| Jun 30, 2021 | 8.48 Mn |